Resource Center

Explore our comprehensive library of clinical publications, abstracts, news, events, newsletters, marketing materials and press releases.
Discover how Pulsenmore is shaping the future of healthcare delivery

Filter By:

Search
resources-top-bg
resources-bottom-bg

the news pulse

We invite you to keep up to date with the latest updates by registering to our quarterly newsletter

news-pulse-doctor
news-pulse-lady1
news-pulse-couple
news-pulse-lady2
about-collaborations-bottom-bg

FAQ

Frequently asked question

Yes, the device is reliable and was tested, validated and approved for use in the US, Europe, Australia, Brazil, Switzerland, the UK, Colombia and Israel. Over 200,000 successful scans have been performed since the launch of the technology. These numbers demonstrate that women can confidently scan themselves, as the diagnoisis it self is being done by a trained clinical team. The remote clinical team can accurately identify parameters related to fetal vitality, such as fetal heartbeat, fetal movements, and amniotic fluid volume, based on these scans.

The Pulsenmore solution utilizes your smartphone’s processing and video streaming capabilities, communication protocols, display, and power resources. For this reason, not all smartphones meet the compatibility requirements. To insure your smartphone is compatible with the Pulsenmore Home Ultrasound check the Specification webpage.

Our commitment to patient safety and reliable scans guides the device’s design and functionality. The Pulsenmore device, connecting to a patient’s personal smartphone, optimally utilizes smartphone capabilities, minimizing material and resource consumption for enhanced environmental sustainability.

1. The Pulsenmore self-scan device is designed for use within a specific timeframe and usage limit. Extending its lifetime may compromise reading integrity due to material limitations.

2. Responsibility for device maintenance and home storage after the initial period cannot be assumed, impacting transducer quality and ultrasound scan reliability.

3. The device design and validated cleaning protocol do not allow transfer between patients, to avoid cross contamination and infection.

No, the product is subject to use in single pregnancies only.

The home ultrasound device is designed to provide continuity during pregnancy care and is intended to give you peace of mind.

Every scan requires medical interpretation, and it’s important to wait until the files are fully uploaded. You are not expected to understand or interpret the ultrasound scans; just follow the app’s instructions to scan, and receive a response from skilled ultrasound professionals .

Pulsenmore collects four types of data:

• Service logs: Application usage logs, such as performance logs and errors.

• Technical information about the smartphone: Smartphone capabilities, application version, language, etc.

• Clinical information: Ultrasound clips scan time

• Interpreter Data: The identifiers of the clinicians that interpret the scans.me, scan measurements and last menstrual period (LMP).

The Pulsenmore was designed to follow ALARA principles as follows:

The system supports only low frequency (2-5MHz), the duration of the scan is limited up to 3 minutes in the App guided mode, or at the clinician’s discretion in the clinician guided mode, only clinician can modify the ultrasound parameters (i.e., depth, gain, frequency etc.), each scan is enabled only upon the approval of a medical professional.

The health care provider determines the maximum amount of scans that can be performed by the user. The device is limited to up to 50 scans per pregnancy.

Pulsenmore utilizes service logs and technical information to improve services and enhance user experience. Pseudonymized clinical data (also referred as de-identified data in the US) is used for clinical education, training, research and development purposes only.

The device is designed for a single patient use, to prevent cross contamination.

The Pulsenmore Scan Key Code is generated by the HCP or admin within the clinician dashboard interface. It has unique identifiers based on the patient de-identified ID, selected mode (Clinician-Guided or App-Guided), and prescription details (frequency and time of use).The key is automatically transformed into a QR code and shared with the patient via email or SMS.